Keytruda Approved in China for Esophageal Squamous Cell Carcinoma Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter Keytruda is now approved in China for three different types of cancer. Source: Devices & Diagnostics Letter You Might Also Like Smiths Medical Pulls Infusion Pumps, Citing Software Error August 20, 2020 Ridgeback Biotherapeutics to Launch Two Trials of Its COVID-19 Antiviral June 22, 2020 CDRH Extends Response Dates for Marketing Applications March 24, 2020